New CEO and FDA Clearance: A Bright Future for Prescient Therapeutics in 2025 Exciting Developments for Prescient Therapeutics With new CEO James McDonnell at the helm and FDA clearance for its Investigational New Drug application, 2025 is shaping up to be a pivotal year for Prescient Therapeutics. The company had a successful December quarter, with…
A New Chapter for MicroStrategy Setting the Stage for Growth In a move that is set to shake up the tech industry, MicroStrategy Incorporated has announced the pricing of its offering of 7,300,000 shares of 8.00% Series A Perpetual Strike Preferred Stock. This bold step demonstrates the company’s commitment to innovation and expansion, as it…
Highlighting a 55% Increase in Tesla Users, Now Over 700K+ Since Jan. 1st Including 350K+ Ad-Supported Tesla Users LOS ANGELES, Jan. 31, 2025 (GLOBE NEWSWIRE) — LiveOne (Nasdaq: LVO), an award-winning, creator-first, music, entertainment, and technology platform, is pleased to report Chairman and CEO, Robert Ellin, will be presenting at Trump Mar-O-Lago, Florida, January 31st,…
Welcome to the Expansion of Retrieve Medical, Inc. Exciting News Alert! Hey there, health enthusiasts! Have you heard the latest scoop? Retrieve Medical, Inc. has just announced its big move into the ambulatory care sector. Yes, you read that right! Our favorite healthcare solution provider is spreading its wings and diving into the world of…
The Impact of Oatly’s ADR Ratio Change Introduction On January 31, 2025, Oatly Group AB announced that it will be changing the ratio of its American Depositary Receipts (ADRs) to ordinary shares. This change will see one ADR now representing twenty ordinary shares, as opposed to the previous ratio of one-to-one. Reasons Behind the Change…
Erasca, Inc. Announces Participation in Guggenheim Securities SMID Cap Biotech Conference SAN DIEGO, Jan. 31, 2025 (GLOBE NEWSWIRE) — Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced its participation in the Guggenheim Securities SMID Cap Biotech Conference being…
Welcome to the Exciting World of Antibiotics! A Major Announcement from Iterum Therapeutics plc Hey there, folks! Have you ever found yourself in a situation where you need antibiotics to battle a nasty infection, only to discover that the usual ones just aren’t cutting it? Well, fear not, because Iterum Therapeutics plc has got your…
Seeking Justice for Investment Losses in Crocs, Inc. Recovering Your Losses Have you recently suffered a financial loss due to your investment in Crocs, Inc. (NASDAQ:CROX)? If so, you may have legal options available to you under the federal securities laws. It can be devastating to see your hard-earned money disappear before your eyes, but…
